doi:10.3969/j.issn.1004-583X.2022.04.014

Abstract

CLC Number:

Add to citation manager EndNote|Ris|BibTeX

URL: https://lchc.magtechjournal.com/EN/10.3969/j.issn.1004-583X.2022.04.014

https://lchc.magtechjournal.com/EN/Y2022/V37/I4/358

References 44

[1]	刘姚江, 赵晓晏. 内镜黏膜下剥离术治疗食管早癌及癌前病变研究进展[J]. 中国实用内科杂志, 2018, 38(3):252-255.
[2]	Park HC, Kim DH, Gong EJ. et al. Ten-year experience of esophageal endoscopic submucosal dissection of superficial esophageal neoplasms in a single center[J]. Korean J Intern Med, 2016, 31(6): 1064-1072. doi: 10.3904/kjim.2015.210 URL
[3]	Nonaka K, Arai S, Ishikawa K. et al. Short term results of endoscopic submucosal dissection in superficial esophageal squamous cell neoplasms[J]. World J Gastrointest Endosc, 2010, 2(2): 69-74. doi: 10.4253/wjge.v2.i2.69 URL
[4]	Abe S, Iyer PG, Oda I. et al. Approaches for stricture prevention after esophageal endoscopic resection[J]. Gastrointest Endosc, 2017, 86(5): 779-791. doi: 10.1016/j.gie.2017.06.025 URL
[5]	李贞娟, 柴宁莉, 李隆松, 等. 大面积食管早期癌内镜下切除术后食管狭窄的影响因素分析[J]. 中华消化内镜杂志, 2021, 38(4): 293-298.
[6]	Ono S, Fujishiro M, Niimi K. et al. Predictors of postoperative stricture after esophageal endoscopic submucosal dissection for superficial squamous cell neoplasms[J]. Endoscopy, 2009, 41(8): 661-665. doi: 10.1055/s-0029-1214867 pmid: 19565442
[7]	Yamaguchi N, Isomoto H, Nakayama T. et al. Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma[J]. Gastrointest Endosc, 2011, 73(6): 1115-1121. doi: 10.1016/j.gie.2011.02.005 pmid: 21492854
[8]	Li L, Linghu E, Chai N. et al. Clinical experience of using a novel self-help inflatable balloon to prevent esophageal stricture after circumferential endoscopic submucosal dissection[J]. Dig Endosc, 2019, 31(4): 453-459. doi: 10.1111/den.13385 URL
[9]	中华医学会消化内镜学分会消化内镜隧道技术协作组, 中国医师协会内镜医师分会, 北京医学会消化内镜学分会. 中国食管良恶性狭窄内镜下防治专家共识(2020, 北京)[J]. 中华消化内镜杂志, 2021, 38(3):173-185.
[10]	Wen J, Lu Z, Yang Y. et al. Preventing stricture formation by covered esophageal stent placement after endoscopic submucosal dissection for early esophageal cancer[J]. Dig Dis Sci, 2014, 59(3): 658-663. doi: 10.1007/s10620-013-2958-5 URL
[11]	Saito Y, Tanaka T, Andoh A. et al. Usefulness of biodegradable stents constructed of poly-l-lactic acid monofilaments in patients with benign esophageal stenosis[J]. World J Gastroenterol, 2007, 13(29): 3977-3980. doi: 10.3748/wjg.v13.i29.3977 URL
[12]	Hair CS, Devonshire DA. Severe hyperplastic tissue stenosis of a novel biodegradable esophageal stent and subsequent successful management with high-pressure balloon dilation[J]. Endoscopy, 2010, 42(Suppl 2): E132-E133. doi: 10.1055/s-0029-1244011 URL
[13]	Kobayashi S, Kanai N, Ohki T. et al. Prevention of esophageal strictures after endoscopic submucosal dissection[J]. World J Gastroenterol, 2014, 20(41): 15098-15109. doi: 10.3748/wjg.v20.i41.15098 URL
[14]	Kataoka M, Anzai S, Shirasaki T. et al. Efficacy of short period, low dose oral prednisolone for the prevention of stricture after circumferential endoscopic submucosal dissection (ESD) for esophageal cancer[J]. Endosc Int Open, 2015, 3(2): E113-E117. doi: 10.1055/s-0034-1390797 URL
[15]	Zhou G, Yuan F, Cai J. et al. Efficacy of prednisone for prevention of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma[J]. Thorac Cancer, 2017, 8(5): 489-494. doi: 10.1111/1759-7714.12473 URL
[16]	Kadota T, Yoda Y, Hori K. et al. Prophylactic steroid administration against strictures is not enough for mucosal defects involving the entire circumference of the esophageal lumen after esophageal endoscopic submucosal dissection (ESD)[J]. Esophagus, 2020, 17(4):440-447. doi: 10.1007/s10388-020-00730-z URL
[17]	Hashimoto S, Kobayashi M, Takeuchi M. et al. The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection[J]. Gastrointest Endosc, 2011, 74(6):1389-1393. doi: 10.1016/j.gie.2011.07.070 pmid: 22136782
[18]	Hanaoka N, Ishihara R, Uedo N. et al. Refractory strictures despite steroid injection after esophageal endoscopic resection[J]. Endosc Int Open, 2016, 4(3): E354-E359. doi: 10.1055/s-0042-100903 URL
[19]	阮荣蔚, 俞江平, 陶亚利, 等. 表浅食管癌内镜黏膜下剥离术后局部单次注射曲安奈德预防狭窄疗效观察[J]. 世界华人消化杂志, 2019, 27(21):1313-1319.
[20]	Misumi Y, Nonaka K, Kishino M. Safer local injection of triamcinolone acetonide for preventing post-endoscopic submucosal dissection esophageal stenosis[J]. Dig Endosc, 2021, 33(4):e77-e78.
[21]	Kawaguchi K, Kurumi H, Takeda Y. et al. Management of strictures after endoscopic submucosal dissection for superficial esophageal cancer[J]. Ann Transl Med, 2017, 5(8): 184. doi: 10.21037/atm.2017.04.22 pmid: 28616399
[22]	Zhang YX, Zhang SN. Clinical application and mechanism of botulinum toxin type A in scar treatment[J]. Zhonghua Shao Shang Za Zhi, 2021, 37(8):705-710.
[23]	Wen J, Lu Z, Linghu E. et al. Prevention of esophageal strictures after endoscopic submucosal dissection with the injection of botulinum toxin type A[J]. Gastrointest Endosc, 2016, 84(4): 606-613. doi: 10.1016/j.gie.2016.03.1484 URL
[24]	李纯纯, 陈炳芳, 张银. 丝裂霉素治疗食管良性狭窄的临床应用进展[J]. 实用医学杂志, 2021, 37(11): 1377-1381.
[25]	Machida H, Tominaga K, Minamino H. et al. Locoregional mitomycin C injection for esophageal stricture after endoscopic submucosal dissection[J]. Endoscopy, 2012, 44(6): 622-625. doi: 10.1055/s-0032-1306775 pmid: 22638783
[26]	Wang H, Shuai Q, Tang J. et al. Local thymosin beta4 Gel injection prevents esophageal stricture after circumferential endoscopic submucosal dissection in a porcine model[J]. Dig Dis, 2019, 37(2): 87-92. doi: 10.1159/000492216 pmid: 30428463
[27]	Fu K, Wu H, Su Z. Self-assembling peptide-based hydrogels: Fabrication, properties, and applications[J]. Biotechnol Adv, 2021, 49:107752. doi: 10.1016/j.biotechadv.2021.107752 URL
[28]	Subramaniam S, Kandiah K, Chedgy F. et al. A novel self-assembling peptide for hemostasis during endoscopic submucosal dissection: A randomized controlled trial[J]. Endoscopy, 2021, 53(1): 27-35. doi: 10.1055/a-1198-0558 URL
[29]	Oumrani S, Barret M, Beuvon F. et al. Prevention of esophageal stricture after circumferential endoscopic submucosal dissection using a modified self-assembling peptide[J]. Dis Esophagus, 2021, 34(8):doaa133.
[30]	Iizuka T, Kikuchi D, Yamada A, et al. Polyglycolic acid sheet application to prevent esophageal stricture after endoscopic submucosal dissection for esophageal squamous cell carcinoma[J]. Endoscopy, 2015, 47(4): 341-344. doi: 10.1055/s-0034-1390770 URL
[31]	Sakaguchi Y, Tsuji Y, Ono S. et al. Polyglycolic acid sheets with fibrin glue can prevent esophageal stricture after endoscopic submucosal dissection[J]. Endoscopy, 2015, 47(4): 336-340. doi: 10.1055/s-0034-1390787 pmid: 25314328
[32]	Chai NL, Feng J, Li LS. et al. Effect of polyglycolic acid sheet plus esophageal stent placement in preventing esophageal stricture after endoscopic submucosal dissection in patients with early-stage esophageal cancer: A randomized, controlled trial[J]. World J Gastroenterol, 2018, 24(9): 1046-1055. doi: 10.3748/wjg.v24.i9.1046 URL
[33]	Li L, Linghu E, Chai N. et al. Efficacy of triamcinolone-soaked polyglycolic acid sheet plus fully covered metal stent for preventing stricture formation after large esophageal endoscopic submucosal dissection[J]. Dis Esophagus, 2019, 32(2).
[34]	Kono M, Nagami Y, Fujiwara Y. Easier attachment technique of polyglycolic acid sheet using thin-endoscope for prevention of stricture after esophageal endoscopic submucosal dissection[J]. Dig Endosc, 2021, 33(6):e114-e116.
[35]	Tang J, Ye S, Ji X. et al. Deployment of carboxymethyl cellulose sheets to prevent esophageal stricture after full circumferential endoscopic submucosal dissection: A porcine model[J]. Dig Endosc, 2018, 30(5): 608-615. doi: 10.1111/den.13070 URL
[36]	Lua GW, Tang J, Liu F. et al. Prevention of esophageal strictures after endoscopic submucosal dissection: A promising therapy using carboxymethyl cellulose sheets[J]. Dig Dis Sci, 2016, 61(6): 1763-1769. doi: 10.1007/s10620-016-4034-4 URL
[37]	Liao Z, Liao G, Yang X. et al. Transplantation of autologous esophageal mucosa to prevent stricture after circumferential endoscopic submucosal dissection of early esophageal cancer (with video)[J]. Gastrointest Endosc, 2018, 88(3): 543-546. doi: 10.1016/j.gie.2018.04.2349 URL
[38]	Isomoto H, Yamaguchi N, Nakayama T. et al. Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma[J]. BMC Gastroenterol, 2011, 11:46. doi: 10.1186/1471-230X-11-46 pmid: 21542926
[39]	Liu Y, Li Z, Dou L. et al. Autologous esophageal mucosa with polyglycolic acid transplantation and temporary stent implantation can prevent stenosis after circumferential endoscopic submucosal dissection[J]. Ann Transl Med, 2021, 9(7):546. doi: 10.21037/atm-20-6987 URL
[40]	Hochberger J, Koehler P, Wedi E. et al. Transplantation of mucosa from stomach to esophagus to prevent stricture after circumferential endoscopic submucosal dissection of early squamous cell[J]. Gastroenterology, 2014, 146(4): 906-909. doi: 10.1053/j.gastro.2014.01.063 pmid: 24512802
[41]	Yu M, Tan Y, Liu D. Strategies to prevent stricture after esophageal endoscopic submucosal dissection[J]. Ann Transl Med, 2019, 7(12): 271.
[42]	Coffin E, Grangier A, Perrod G. et al. Extracellular vesicles from adipose stromal cells combined with a thermoresponsive hydrogel prevent esophageal stricture after extensive endoscopic submucosal dissection in a porcine model[J]. Nanoscale, 2021, 13(35):14866-14878. doi: 10.1039/d1nr01240a pmid: 34533159
[43]	Ohki T, Yamato M, Murakami D. et al. Treatment of oesophageal ulcerations using endoscopic transplantation of tissue-engineered autologous oral mucosal epithelial cell sheets in a canine model[J]. Gut, 2006, 55(12): 1704-1710. pmid: 16709659
[44]	Perrod G, Pidial L, Camilleri S. et al. ADSC-sheet transplantation to prevent stricture after extended esophageal endoscopic submucosal dissection[J]. J Vis Exp, 2017,(120):55018.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 44

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Su Rui, Wang Cunkai, Wang Dingxin, Cai Conghui, Zhang Jian, Hou Hongtao, Bai Yun. Efficacy and safety of anticoagulant therapy in patients with cirrhosis: A meta-analysis [J]. Clinical Focus, 2025, 40(4): 293-303.
[2]	Qi Xueting, Li Guona, Xue Rong, Zhang Junfang, Jia Jingjing, Huang Wenhui, Li Yingping. Characteristics of single-center peritoneal dialysis-associated peritonitis [J]. Clinical Focus, 2025, 40(4): 334-338.
[3]	. [J]. Clinical Focus, 2025, 40(4): 377-380.
[4]	Lin Tao, Du Taoming, Li Ya, Feng Yuling, Song Huizhen, Yu Qin. Value of T₂WI signal intensity and gadobemeglumine enhanced MRI hepatobiliary phase parameters in evaluating liver function of cirrhosis patients [J]. Clinical Focus, 2025, 40(3): 251-256.
[5]	Tong Mingxia, Chen Ke, Xiang Xiaocong, Zhou Lifeng. Analysis of lean metabolic-associated fatty liver disease among young and middle-aged people and its risk factors [J]. Clinical Focus, 2025, 40(2): 128-132.
[6]	Qian Chenying, Yan Wenjun, Huang Yan, Zhao Zhi. Analysis of risk factors for multidrug-resistant bacterial infection in patients with decompensated cirrhosis [J]. Clinical Focus, 2025, 40(2): 143-146.
[7]	Sun Ya, Yang Shuang. Value of ultrasound-guided attenuation parameter in the quantitative assessment of hepatic steatosis [J]. Clinical Focus, 2025, 40(2): 158-161.
[8]	Gou Caixia, Zhang Jie, Baoyixiamu·Ababaikeli , Wang Yiming, Yao Lei, Zheng Rongjiong, Pan Jinliang, Lu Xiaobo. Analysis of influencing factors of sleep quality and metabolically associated fatty liver disease in the physical examination population [J]. Clinical Focus, 2025, 40(1): 33-38.
[9]	Hu Rongqiu, Yan Le. Causal relationship between reflux esophagitis and otitis media: a two-sample Mendelian randomization analysis in the European population [J]. Clinical Focus, 2024, 39(12): 1089-1094.
[10]	. [J]. Clinical Focus, 2024, 39(12): 1125-1130.
[11]	Zhang Shasha, Zhao Yingchun, Zhou Hongxia. Effect of low-level viremia on the incidence of hepatocellular carcinomas in patients with hepatitis B cirrhosis treated with entecavir [J]. Clinical Focus, 2024, 39(11): 980-983.
[12]	. [J]. Clinical Focus, 2024, 39(11): 1035-1039.
[13]	. [J]. Clinical Focus, 2024, 39(10): 935-939.
[14]	Qin Qiaoling, Mo Ranghui, Chen Xinyi. Efficacy and safety of the direct-acting anti-HCV therapy based on efavirenz-containing regimen on HIV/HCV co-infected patients [J]. Clinical Focus, 2024, 39(10): 921-924.
[15]	Li Zhenan, Zhu Xuejuan, Li Shang, Wang Junmin. Effect of glucocorticoids with varied courses on the prevention of esophageal stricture after esophageal submucosal dissection [J]. Clinical Focus, 2024, 39(10): 896-900.